Meet the robots

Videos: Robotics company unveils its Houston operation at the Texas Medical Center

ABB's mobile YuMi robot cut the ribbon on its new home in the Texas Medical Center. Cody Duty/TMC

Houston has a new fleet of robots training to better streamline health care operations. ABB Robotics cut the ribbon of its Texas Medical Center incubator on Wednesday, October 9.

"This is really an exciting day for us at ABB because we are opening up our innovation hub in a globally unique place at the Texas Medical Center," says Sami Atiya, president of Robotics and Discrete Automation at ABB, at the grand opening event.

According to ABB research, the industry expects 60,000 non-surgical medical robots by 2025, which is four times that of 2018. Zurich-based ABB has 400,000 robotics products across industries in over 53 companies, but this is their first dedicated health care center. The 5,300-square-foot space located in TMC Innovation Institute, which was announced earlier this year, will have around 20 employees in the facility managing robots conducting a myriad of tasks.

The potential for collaboration between ABB and TMC is just getting started with the hub space. ABB already has connections with TMC's member institutions and ABB also recognizes the innovation avenues the TMC brings to the table.

"This is not only about the chance to interact with 25 hospitals," Atiya says. "We have the chance to interact with bright startups, bright academia, and with an ecosystem that is unique. We really looked around the world to set up this business because we need to learn. We need to interact."

One way TMC's CEO, William McKeon sees a huge opportunity for robots is in the inventory process. Right now, each hospital manages its own inventory process with its own team of employees. McKeon explains how that process can be streamlined and better organized using robotics.

"It may not be as exciting as some of the things you see here [in the hub], but it's equally as meaningful and economically important in lowering our health care costs," McKeon says.

YuMi cuts the ribbon on the new ABB facility in the Texas Medical Center

The mobile YuMi robot cut the ribbon of its new home.

BrainCheck has moved to a new office as it grows its team and expands its product. Natalie Harms/InnovationMap

Following a series A round of fundraising, a Houston digital health startup is on a bit of a hiring spree, leading to new office space the company has room to grow into.

BrainCheck, which was founded in 2015 by neuroscientist David Eagleman, is a cognitive assessment startup that has developed a software tool for primary care doctors to use to assess their patients' cognitive health so that they can more quickly diagnose and treat them for maladies like dementia.

The 19-person company headquartered in Houston — with a secondary office in Austin focused on product development — has relocated its operations from coworking space in the Texas Medical Center to an office in the Rice Village area. The move was made possible by an $8 million series A financing round that closed in October.

"It's pretty exciting to have reached this milestone where we need more space," Yael Katz, co-founder and CEO of BrainCheck, tells InnovationMap. "We were pretty much bursting at the seams in our old office."

The move comes at a time when the company is building out its team. Katz says she is looking to fill a few roles within marketing, sales, and R&D. The team expects to expand to around 25 people by the end of Q1 and then again to 32 employees by the end of the year.

The new positions are needed in part to support the company's product development growth. Rather than just assessing cognitive health, BrainCheck is piloting some automated care plan technology.

"We have a lot of new product development that's underway," Katz says. "A big focus is expanding the output of the cognitive assessment into the cognitive care management."

Following the BrainCheck assessment, this new software will automate a cognitive care plan that doctors can then customize for his or her patients.

"The care plan process right now takes a very long time for the doctors to do, and therefore is very seldom done," Katz says.

And, in some cases, care plans aren't done because there's no cure or limited medications that help these types of cognitive diseases.

"A lot of people think of dementia sometimes as something there's no treatment for," Katz says. "It's true that there are limited pharmaceutical treatments for it, but there's evidence that comprehensive management of the disease is effective."

BrainCheck has opened the door on cognitive assessment. Traditional cognitive assessment used to only be done through a lengthy process and only by a small group of neuropsychologists. It's difficult for patients to find a neuropsychologist and then book an appointment.

"There's a big need to empower primary care doctors to have that ability to assess and manage patients' cognitive help," Katz says, explaining that this creates a perfect market for BrainCheck.